A carregar...
Targeting the ERK Signaling Pathway in Melanoma
The discovery of the role of the RAS/RAF/MEK/ERK pathway in melanomagenesis and its progression have opened a new era in the treatment of this tumor. Vemurafenib was the first specific kinase inhibitor approved for therapy of advanced melanomas harboring BRAF-activating mutations, followed by dabraf...
Na minha lista:
| Publicado no: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6472057/ https://ncbi.nlm.nih.gov/pubmed/30934534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20061483 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|